Full history for every metric is available with a Kvantra account

Stock profile

Waverunner Capital Inc. (CHM.CN)

Country: CanadaSector: HealthcareIndustry: Drug Manufacturers - Specialty & GenericExchange: CNQ

Delisted · last close 16 Jul 2024

Current price
0.01 CAD-50.00%
Last close 16 Jul 2024
Benchmarks

Key financial summary

Financials in CAD
201920202021202220232024TTM
Total revenueCAD m0001000
Operating profitCAD m-1-1
Net profitCAD m-5-5-5-3-1-4-4
EPS reportedCAD-0.67-0.55
Operating cashflow per shareCAD-0.07-0.07
Capex per shareCAD0.000.00
FCF per shareCAD-0.07-0.07
Free cash flowCAD m-0-0
Net debtCAD m00
Book value equityCAD m-0-1
Book value per shareCAD-0.04-0.14
Number of sharesm6.24.96
DPS (TTM paid)CAD0.000.00

Financial summary

Financials in CAD
201920202021202220232024TTM
Value
P/E TTMx--
P/B LTMx-0.23-52.72
P/S LTMx0.000.00
P/FCF LTMx-0.15-120.33
EV/EBITDA LTMx0.00-9.76
EV/Sales LTMx0.000.00
Earnings Yield LTM%-6709.4%-1341.9%
FCF Yield%-677.19%-0.83%
Quality
ROE%1523.6%115.90%
ROIC%-365.82%-365.82%
Operating margin%0.00%0.00%
Gross margin%0.00%0.00%
FCF/Sales%--
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%-100.00%-100.00%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx-0.95-0.70
Net Debt/EBITDAx0.000.00
EBIT/Net interestx-0.77-0.77
Net debt/market cap%387.23%1.09%
Net debt/Equityx-0.88-0.57
Gross debt/equityx-1.63-0.63

Company overview

Waverunner Capital Inc., established in North Vancouver, Canada, in 2008, is a venture capital firm that funds various stages of business development. The company specializes in early-stage, seed, and startup financing, alongside Private Investment in Public Equity (PIPEs), bridge funding, recapitalizations, and providing growth capital. It also acquires secondary limited partner interests. Waverunner Capital actively seeks investment opportunities across Europe and North America, deploying capital from its own balance sheet and personal funds. The firm typically targets equity investments ranging from Can$500,000 (US$345 million) to Can$1 million (US$694 million), focusing on companies with an enterprise value between Can$2 million (US$138 million) and Can$5 million (US$347 million). Its diverse portfolio includes stakes in the resources industry, renewable energy projects (both wind and solar), a plant-based wellness company, and a biotechnology venture aimed at consumers. The company adopted its current name, Waverunner Capital Inc., in June 2024, having previously been known as Chemistree Technology Inc.

WebsiteN/A
IndustryDrug Manufacturers - Specialty & Generic
CountryCanada
Trades inCAD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 16 Jul 2024

Waverunner Capital Inc. (CHM.CN)

CHM.CN · CNQ · Healthcare
0.01 CAD-50.00%
Benchmarks
Financialsin CAD
20232024TTM
About

Waverunner Capital Inc., established in North Vancouver, Canada, in 2008, is a venture capital firm that funds various stages of business development. The company specializes in early-stage, seed, and startup financing, alongside Private Investment in Public Equity (PIPEs), bridge funding, recapitalizations, and providing growth capital. It also acquires secondary limited partner interests. Waverunner Capital actively seeks investment opportunities across Europe and North America, deploying capital from its own balance sheet and personal funds. The firm typically targets equity investments ranging from Can$500,000 (US$345 million) to Can$1 million (US$694 million), focusing on companies with an enterprise value between Can$2 million (US$138 million) and Can$5 million (US$347 million). Its diverse portfolio includes stakes in the resources industry, renewable energy projects (both wind and solar), a plant-based wellness company, and a biotechnology venture aimed at consumers. The company adopted its current name, Waverunner Capital Inc., in June 2024, having previously been known as Chemistree Technology Inc.

IndustryDrug Manufacturers - Specialty & Generic
CountryCanada
Trades inCAD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free